期刊文献+

调Q1 064nmNd:YAG激光联合LED红光治疗面部糖皮质激素依赖性皮炎疗效分析 被引量:8

Clinical efficacy of LED red light combined with Q-switched Nd:YAG 1 064 nm laser in treating the facial corticosteroid dependent dermatitis
下载PDF
导出
摘要 目的:探讨调Q1 064nm Nd:YAG激光联合LED红光治疗面部糖皮质激素依赖性皮炎的疗效。方法:30例面部糖皮质激素依赖性皮炎患者,随机分为联合治疗组和对照组,每组各15例。所有患者均给予LED红光照射治疗,15min/次,2次/周。联合治疗组每周加做1次调Q1 064nm Nd:YAG激光治疗。疗程共5周,分别于治疗第1、3、5周时做疗效判定。结果:第1周治疗后,两组患者症状均有改善,但两组患者有效率差异无统计学意义(P>0.05),但联合治疗组在治疗第3周、第5周后的有效率均显著高于对照组,差异有统计学意义(P<0.05)。结论:调Q1 064nm Nd:YAG激光联合LED红光治疗面部糖皮质激素依赖性皮炎疗效显著。 Objective To study the Clinical efficacy of LED red light combined with Q-switched Nd:YAG 1 064 nm laser in treating the facial corticosteroid dependent dermatitis. Methods 30 cases with facial corticosteroid dependent dermatitis were randomly divided into two groups, Combined treatment group and Control group Each had 15 cases All patients were treated with LED red light irradiation, 15 minutes per time, twice a week. The control group was combined with Q-switched Nd:YAG 1 064 nm laser in treating the patients. The course of treatment was 5 weeks. The effect was measured respectively at week 1,3and 5. Results The symptoms of the two groups were improved after the first week, but there was no significant difference between the two groups(P 0.05), The effective rates of the combined treatment group were significantly higher than control group in the third week and the fifth week, and the difference was statistically significant(P0.05). Conclusion LED red light combined with Q-switched Nd:YAG 1 064 nm laser may be a safe and effective option for treating the patients with facial corticosteroid dependent dermatitis.
出处 《中国美容医学》 CAS 2016年第1期48-50,共3页 Chinese Journal of Aesthetic Medicine
基金 国家自然科学基金青年项目(编号:81402259)
关键词 面部糖皮质激素依赖性皮炎 LED红光 调Q1 064nm ND:YAG激光 光热作用 facial corticosteroid dependent dermatitis LED red light Q-switched Nd:YAG 1 064 nm laser photothermy
  • 相关文献

参考文献9

二级参考文献24

  • 1杜晓航,宋为民.糖皮质激素性皮炎的研究进展[J].国外医学(皮肤性病学分册),2005,31(5):268-270. 被引量:59
  • 2田分,张守民.激素依赖性皮炎及其诊疗[J].医学综述,2005,11(10):911-913. 被引量:59
  • 3Shimizu M,Saitoh Y,Itoh H.immunohistochemical staining of Haras oncogene product in normal,benign,and malignant human pancreatic tissues.Hum Pathol,1990,21 (6):607-612.
  • 4Fartasch M.The epidermal lamellar body:a fascinating secretory organelle.J Invest Dermatol,2004,122(5):Ⅺ-Ⅻ.
  • 5Kolbe L,Kligman AM,Schreiner V,et al.Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin.Skin Res Technol,2001,7(2):73-77.
  • 6Bayo P,Sanchis A,Bravo A,et al.Glucocorticoid receptor is required for skin barrier competence.Endocrinology,2008,149(3):1377-1388.
  • 7Sheu HM,Tai CL,Kuo KW,et al.Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids.J Dermatol,1991,18(8):454-464.
  • 8Kao JS,Fluhr JW,Man MQ,et al.Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity:inhibition of epidermal lipid synthesis accounts for functional abnormalities.J Invest Dermatol,2003,120(3):456-464.
  • 9乔志恒 等.新编物理治疗学[M].北京:华夏出版社,1993..
  • 10Ljubojeviae S,Basta-Juzbasiae A,Lipozeneiae J.Steroid dermatitis resembling rosacea:aetiopathogenesis and treatment.J Eur Acad Dermatol Venereol,2002,16(2):121-126.

共引文献247

同被引文献73

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部